JAMES W. YOUNG, PH.D. - Corporate Board Profile

Viracta Therapeutics, Inc.

Filing Date	Source Excerpt
2008-04-29	James W. Young, Ph.D. has served as our Executive Chairman since December 2003. From May 2000 to November 2003, Dr. Young served as our Chief Executive Officer. ... Dr. Young holds a B.S. in Chemistry from Fordham University and a Ph.D. in Organic Chemistry from Cornell University.
2009-05-20	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. ... Until April 2009, Dr. Young served as our Executive Chairman. ... The following table sets forth the compensation information for our non-employee directors, as well as Dr. Young, the current Chairman of our Board and former Executive Chairman, for the year ended December 31, 2008. ... As of December 31, 2008, Dr. Young held stock options to purchase 329,118 shares of our common stock. He did not receive any equity awards in 2008. "All Other Compensation" includes Dr. Young’s annual salary of $200,000 and group term life insurance payments of $2,772. Total $410,302.
2010-04-29	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. Dr. Young also served as a director of Corixa Corporation, a biopharmaceutical company, from 2000 to July 2005. The Board has concluded that Dr. Young should serve on our Board due to Dr. Young's prior history as chief executive officer and his long tenure as Board Chair, which brings continuity to the Board and a depth of understanding. On the date of our annual meeting of stockholders each year, a non-employee Chairman of our Board is entitled to receive $50,000 in connection with his or her services as a director and chair of our Board. Dr. Young's total compensation for 2009 was $130,512.
2011-04-21	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. ... The following table sets forth the compensation information for our non-employee directors, as well as Dr. Young, the current Chairman of our Board and former Executive Chairman, for the year ended December 31, 2010. ... James W. Young, Ph.D. Fees Earned or Paid in Cash $50,000, Option Awards $5,393, All Other Compensation $9,511, Total $64,904.
2012-04-23	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. The Board has concluded that Dr. Young should serve on our Board due to his prior history as our Chief Executive Officer and his long tenure as Board Chairman. Director Compensation Table shows total compensation of $137,228.
2013-04-25	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. ... The Board is currently chaired by Dr. Young, Sunesis former Executive Chairman. ... On the date of our annual meeting of stockholders and on the three-month anniversary thereof for the subsequent three quarters, each non-employee director of our Board (other than the Board Chairman) is entitled to receive a quarterly payment of $7,500 and the non-employee Board Chairman is entitled to receive a quarterly payment of $12,500, each in connection with his or her services as a director and Board Chairman, respectively. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2012. ... James W. Young, Ph.D. total compensation $110,576.
2014-04-24	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. The non-employee Board Chairman is entitled to receive a quarterly payment of $15,000. The compensation table shows total compensation of $118,546 for 2013.
2015-04-28	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. From May 2000 to November 2003, Dr. Young served as our Chief Executive Officer. In April 2006, he joined 5AM Ventures, a venture capital firm, as a Venture Partner. From September 1995 to March 2000, Dr. Young served as Vice President of Research, as Senior Vice President, Research and Development, and as Group Vice President at ALZA Corporation, a pharmaceutical company. From September 1992 to August 1995, Dr. Young served as Senior Vice President for Business Development and as President of the Pharmaceuticals Division of Affymax, N.V., a biopharmaceutical company. From September 1987 to August 1992, he served as Senior Vice President for Business Development and as Senior Vice President and General Manager of the Pharmaceuticals Division at Sepracor Inc., a pharmaceutical company. Dr. Young also served as a director of Corixa Corporation, a biopharmaceutical company, from 2000 to July 2005. Dr. Young holds a B.S. in Chemistry from Fordham University and a Ph.D. in Organic Chemistry from Cornell University. The Board has concluded that Dr. Young should serve on our Board due to his prior history as our Chief Executive Officer and his long tenure as Board Chairman, which brings continuity to the Board and a depth of understanding. In addition, the Board believes that he brings operational and industry expertise due to his experience in management of other pharmaceutical and biopharmaceutical companies, as well as leadership skills that are important to the Board. Director Compensation Table: James W. Young, Ph.D. Fees Earned or Paid in Cash ($): $60,000, Option Awards ($): $87,038, Total ($): $147,038.
2016-04-25	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. The Director Compensation Table shows total compensation of $144,652.
2017-04-20	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. ... The Board has concluded that Dr. Young should serve on our Board due to his prior history as our Chief Executive Officer and his long tenure as Board Chairman, which brings continuity to the Board and a depth of understanding. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2016. James W. Young, Ph.D. received total compensation of $81,740.
2018-04-25	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. ... The Board has concluded that Dr. Young should serve on our Board due to his prior history as our Chief Executive Officer and his long tenure as Board Chairman, which brings continuity to the Board and a depth of understanding. ... On December 12, 2017, Dr. Pearce presented the Nominating and Corporate Governance Committee’s recommendation that, effective December 31, 2017, Mr. Misfeldt step down from his committee membership and that Dr. Young be appointed to the Audit Committee. ... James W. Young, Ph.D. 60,000 fees earned, 58,915 option awards, total 118,915.
2019-04-12	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. ... Dr. Young served on the Audit Committee until Mr. Wolff became a director and as the chair of the Audit Committee in February 2018. ... Director Compensation Table: James W. Young, Ph.D. Fees Earned or Paid in Cash $62,500, Option Awards $42,740, Total $105,240.
2020-04-28	James W. Young, Ph.D. served as Executive Chairman of our Board from December 2003 to April 2009 and has served as non-executive Chairman of our Board since April 2009. The Board is currently chaired by Dr. Young. The Director Compensation Table shows total compensation of $103,608 for 2019. He serves on the Nominating and Corporate Governance Committee.